Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research

Altogen Labs published a framework in JoVE for selecting and standardizing xenograft models, covering preclinical oncology program design from early efficacy through IND-enabling safety studies. The release is primarily scientific/operational and does not cite financial guidance, so near-term market impact is likely limited.